Building the Intelligence Engine for Drug Discovery R&D Teams: Recent Developments in AI‑Driven Platforms and Workflows
"Building the Intelligence Engine for Drug Discovery R&D Teams" is a virtual industry event scheduled for Tuesday, July 28, 2026, from 10–11am EDT, hosted by Patsnap and featuring Mark Davies (Head of Product, Life Sciences) and James Longden (Senior Director, Life Sciences at Evolvus). The panel will examine how AI‑powered intelligence is reshaping candidate optimization across antibodies, ADCs, and peptides, emphasizing curated data, robust SAR workflows, and the blending of human expertise with AI to turn abundant data into actionable insight for drug discovery. Life sciences teams are also exploring AI‑driven platforms such as Causaly (with Microsoft), agentic AI systems, and AI‑powered IP and competitive‑intelligence engines to connect internal and external data, accelerate target identification, and automate end‑to‑end R&D workflows while maintaining traceable, evidence‑backed decisions.
Sources:
Building the Intelligence Engine for Drug Discovery R&D ...
The future of pharmaceuticals: Artificial intelligence in drug ...
Integrating Artificial Intelligence Across the Drug- Discovery ...
How AI is Transforming Pharma R&D: 5 Key Steps to Build the Future | AI in Healthcare
Microsoft and Causaly Integration Accelerates Biopharma ...
AI In Action: Redefining Drug Discovery and Development
The AI Co-Pilot: Takeda Taps Boltz to Remodel Drug Discovery's DNA - BriefGlance.com
Top 7 Agentic AI Drug Discovery Solutions in 2026 - EUROPE SAYS
Integrating artificial intelligence in drug discovery and early ...
Unleashing the power of generative AI in drug discovery
Causaly Launches AI-powered Competitive Intelligence ...
AI-driven IP Intelligence Engine for Drug Discovery - CORDIS
Artificial Intelligence in Drug Discovery: Accelerate the Path ...
How to Radically Accelerate Drug Discovery and ...
Software powered by artificial intelligence accelerates drug discovery